A study by researchers at Columbia University’s Mailman School of Public Health, Columbia University Medical Center (CUMC), New York State Psychiatric Institute and colleagues in Finland reports an association between smoking during pregnancy and increased risk for schizophrenia in children.
The paper evaluated nearly 1,000 cases of schizophrenia and matched controls among offspring born in Finland from 1983-1998 who were ascertained from the country’s national registry.
The findings persisted after adjusting for factors, including maternal and parental psychiatric history, socioeconomic status, and maternal age.
“To our knowledge, this is the first biomarker-based study to show a relationship between fetal nicotine exposure and schizophrenia,” said Alan Brown, MD, MPH, senior author and Mailman School professor of Epidemiology and professor of Psychiatry at CUMC. “We employed a nationwide sample with the highest number of schizophrenia cases to date in a study of this type.”
Researchers analyzed data from a large national birth cohort of pregnant women who participated in the Finnish Prenatal Study of Schizophrenia and their offspring from the Finnish Maternity Cohort, which archived over 1 million prenatal serum specimens since 1983. Blood was collected during the first and early second trimesters. The Finnish Hospital and Outpatient Discharge Registry was used to identify all recorded diagnoses for psychiatric hospital admissions and outpatient treatment visits.
In a previous study from a different birth cohort, also reported in the American Journal of Psychiatry, Brown and colleagues found that offspring of mothers who reported smoking during pregnancy have an increased risk of bipolar disorder.
Findings are published online in the American Journal of Psychiatry.